Chronic fluoxetine treatment induces lipid accumulation but does not alter the expression of Pref-1 in rat adipose tissue

Acta Pharm. 2018 Mar 1;68(1):109-115. doi: 10.2478/acph-2018-0009.

Abstract

This study aims to investigate the effects of chronic fluoxetine (FLX) treatment on preadipocyte factor-1 (Pref-1) expression in subcutaneous, visceral and brown adipose tissues, and on the size of vacuoles in a dipocytes obtained from the perirenal regions in rats. Twenty-eight Wistar rats were treated with FLX at two different doses and fourteen animals received vehicle. After 40 days of treatment, the subcutaneous, perirenal and interscapular adipose tissues were collected. Pref-1 expression was examined using an immunohistochemical method and the vacuolar area was measured in stained sections. In the low dose FLX group, the size of vacuoles increased both in male and female animals. The high dose of FLX also induced a significant increase of vacuole size, but only in male animals. Neither of the two doses of FLX has significantly affected the Pref-1 expression in any type of adipose tissue.

Keywords: adipose tissue; fluoxetine; preadipocyte factor-1; vacuole size.

MeSH terms

  • Adipose Tissue, Brown / drug effects*
  • Adipose Tissue, Brown / metabolism
  • Animals
  • Female
  • Fluoxetine / pharmacology*
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Lipid Metabolism / drug effects*
  • Lipids / physiology*
  • Male
  • Membrane Proteins / metabolism*
  • Rats
  • Rats, Wistar

Substances

  • Dlk1 protein, rat
  • Intercellular Signaling Peptides and Proteins
  • Lipids
  • Membrane Proteins
  • Fluoxetine